-
Je něco špatně v tomto záznamu ?
Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT
M. Šťastná-Marková, P. Hainz, J. Kryštofová, J. Macková, K. Roubalová, J. Vydra, Š. Němečková
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- akutní myeloidní leukemie * terapie imunologie genetika MeSH
- antigeny nádorové imunologie MeSH
- dospělí MeSH
- homologní transplantace MeSH
- jaderné proteiny genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mucin 1 genetika imunologie MeSH
- mutace * MeSH
- nukleofosmin * MeSH
- proteiny WT1 imunologie genetika MeSH
- recidiva MeSH
- senioři MeSH
- T-lymfocyty * imunologie MeSH
- transplantace hematopoetických kmenových buněk * MeSH
- tyrosinkinasa 3 podobná fms * genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: This study aimed to examine changes in the repertoire of functional T-cells specific for six leukemia-associated antigens (LAA), including WT1, PRAME, MUC1, CCNA1, NPM1, and NPM1c, during immune reconstitution following allogeneic transplantation of hematopoietic stem cells (HSCT) in patients with acute myeloid leukemia. PATIENTS & METHODS: LAA-specific T cell response was measured by ELISPOT- IFNγ and intracellular cytokine staining in 47 patients before starting conditioning therapy (baseline) and 7 months after HSCT. RESULTS: The positive cumulative LAA-specific T cell response before HSCT was associated with a decreased risk of relapse after HSCT. The prevalent genetic aberration - an internal tandem duplication of Fms 3 - related receptor tyrosine kinase, which has been previously implicated in immune escape mechanisms, is presented here for the first time as a factor associated with the absence of an adaptive T cell response against multiple LAAs. T-cell specific responses against wild-type and mutated NPM1 antigens were less frequent in the study cohort and did not correlate with mutations in the NPM1 gene. CONCLUSIONS: Our results showed that the T-cell response to LAA can be reconstituted after HSCT. Measurement of functional pre-transplant T-cell responses against multiple LAAs could help to find patients with an increased risk of relapse.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009969
- 003
- CZ-PrNML
- 005
- 20250429135202.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/1750743X.2025.2478804 $2 doi
- 035 __
- $a (PubMed)40099461
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Šťastná-Marková, Markéta $u Transplantation and Intensive Care Unit, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Institute of Clinical and Experimental Hematology of the 1st Faculty of Medicine of Charles University, Prague, Czech Republic
- 245 10
- $a Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT / $c M. Šťastná-Marková, P. Hainz, J. Kryštofová, J. Macková, K. Roubalová, J. Vydra, Š. Němečková
- 520 9_
- $a AIMS: This study aimed to examine changes in the repertoire of functional T-cells specific for six leukemia-associated antigens (LAA), including WT1, PRAME, MUC1, CCNA1, NPM1, and NPM1c, during immune reconstitution following allogeneic transplantation of hematopoietic stem cells (HSCT) in patients with acute myeloid leukemia. PATIENTS & METHODS: LAA-specific T cell response was measured by ELISPOT- IFNγ and intracellular cytokine staining in 47 patients before starting conditioning therapy (baseline) and 7 months after HSCT. RESULTS: The positive cumulative LAA-specific T cell response before HSCT was associated with a decreased risk of relapse after HSCT. The prevalent genetic aberration - an internal tandem duplication of Fms 3 - related receptor tyrosine kinase, which has been previously implicated in immune escape mechanisms, is presented here for the first time as a factor associated with the absence of an adaptive T cell response against multiple LAAs. T-cell specific responses against wild-type and mutated NPM1 antigens were less frequent in the study cohort and did not correlate with mutations in the NPM1 gene. CONCLUSIONS: Our results showed that the T-cell response to LAA can be reconstituted after HSCT. Measurement of functional pre-transplant T-cell responses against multiple LAAs could help to find patients with an increased risk of relapse.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nukleofosmin $7 D000090243
- 650 12
- $a transplantace hematopoetických kmenových buněk $7 D018380
- 650 12
- $a akutní myeloidní leukemie $x terapie $x imunologie $x genetika $7 D015470
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a tyrosinkinasa 3 podobná fms $x genetika $7 D051941
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a T-lymfocyty $x imunologie $7 D013601
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a antigeny nádorové $x imunologie $7 D000951
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a jaderné proteiny $x genetika $7 D009687
- 650 _2
- $a mucin 1 $x genetika $x imunologie $7 D018396
- 650 _2
- $a proteiny WT1 $x imunologie $x genetika $7 D025721
- 650 _2
- $a homologní transplantace $7 D014184
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hainz, Petr $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Kryštofová, Jitka $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Macková, Jana $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Roubalová, Kateřina $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Vydra, Jan $u Transplantation and Intensive Care Unit, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Institute of Clinical and Experimental Hematology of the 1st Faculty of Medicine of Charles University, Prague, Czech Republic
- 700 1_
- $a Němečková, Šárka $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000160014007
- 773 0_
- $w MED00175821 $t Immunotherapy $x 1750-7448 $g Roč. 17, č. 3 (2025), s. 185-190
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40099461 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135158 $b ABA008
- 999 __
- $a ok $b bmc $g 2311377 $s 1247050
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 17 $c 3 $d 185-190 $e 20250318 $i 1750-7448 $m Immunotherapy $n Immunotherapy $x MED00175821
- LZP __
- $a Pubmed-20250415